BCL2 and Alzheimer disease: On the other hand, the administration of AST and AST-LI to AD-like rats was linked to anti-apoptotic activity, as demonstrated by restoring BCL-2 expression and suppressing caspase-3 activation, BAX, and BAX/BCL2 levels.